| Cell line name |
ACI-35 |
|---|
| Accession |
CVCL_IU13 |
|---|
| Resource Identification Initiative |
To cite this cell line use: ACI-35 (RRID:CVCL_IU13) |
|---|
| Disease |
Ovarian serous adenocarcinoma (NCIt: C7550) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Female |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=19888321; DOI=10.1371/journal.pone.0007670; PMCID=PMC2765613
Bih-Rong Wei, Shelley B. Hoover, Mark M. Ross, Wei-Dong Zhou, Francesco Meani, Jennifer B. Edwards, Elizabeth I. Spehalski, John I. Risinger, W. Gregory Alvord, Octavio A. Quinones, Claudio Belluco ...Show all 21 authors... , Luca Martella, Elio Campagnutta, Antonella Ravaggi, Ren-Ming Dai, Paul K. Goldsmith, Kevin Douglas Woolard, Sergio Pecorelli, Lance Allen Liotta, Emanuel F. Petricoin 3rd, R. Mark Simpson; Show fewer authors
Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.
PLoS ONE 4:e7670.1-e7670.13(2009) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54608392
|
|---|
| Entry history |
|---|
| Entry creation | 03-Mar-2017 |
|---|
| Last entry update | 14-Aug-2025 |
|---|
| Version number | 4 |
|---|
